Abstract
Lung cancer is one of the leading causes of cancer deaths in most Western countries. In the United States it accounts for 33% of the cancer deaths in males and 11% of the cancer deaths in females. More males die from lung cancer than from the four next common cancer sites combined, i. e., colon, prostate, pancreas, and stomach cancer. In females, lung cancer holds third place in cancer deaths, preceded only by breast and colon cancer (Silverberg, 1977). Of all the common cancers it is the one most clearly associated with environmental agents, the most notable of which is cigarette smoking.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alvares, A. P., Kappas, A., Levin, W., Conney, A. H.: Inducibility of benzo[a]pyrene hydroxylase in human skin by polycyclic hydrocarbons. Clin. Pharmacol. Ther. 14, 30 (1973)
Ambre, J., Graeff, D., Bures, F., Haupt, D., Deason, K.: Antipyrine metabolism and bronchogenic carcinoma. J. Med. 8, 57 (1977)
Atlas, S. A., Vesell, E. S., Nebert, D. W.: Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Cancer Res. 36, 4619 (1976)
Bast, R. C., Okuda, T., Plotkin, E., Tarone, R., Rapp, H. J., Gelboin, H. V.: Development of an assay for aryl hydrocarbon [benzo(a)pyrene] hydroxylase in human peripheral blood monocytes. Cancer Res. 36, 1967 (1976)
Boulos, B., MacDougall, M., Shoeman, D., Azarnoff, D.: Evidence that inhibition of hepatic drug oxidation by tumors is mediated by a circulating humor. Proc. Soc. Exp. Biol. Med. 139, 1353 (1972)
Brandenburg, J., Kellermann, G.: Aryl hydrocarbon hydroxylase inducibility in laryngeal carcinomas. Arch. Otolaryngology 104, 151 (1978)
Brodie, B. B., Axelrod, J., Soberman, R., Levy, B.: The estimation of antipyrine in biological materials. J. Biol. Chem. 179, 25 (1949)
Busbee, D., Shaw, C. R., Cantrell, E.: Aryl hydrocarbon hydroxylase induction in human leukocytes. Science 178, 315 (1972)
Cantrell, E. T., Warr, G. A., Busbee, D. L., Martin, R. R.: Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. J. Clin. Invest. 52, 1881 (1973)
Conney, A. H., Burns, J. J.: Metabolic interactions between environmental chemicals and drugs. Science 178, 576 (1972)
Conney, A. H., Kapitulnik, J., Levin, W., Dansette, P., Jerina, D.: Use of drugs in the evaluation of carcinogen metabolism in man. In: Screening tests in chemical carcinogenesis, R. Montesano, H. Bartsch, L. Tomatis, eds., pp. 319—336. Lyon: TARC Scientific Publications, No. 122, 1976
Gelboin, H. V., Kinoshita, N., Wiebel, F. J.: Microsomal hydroxylases: Induction and role in polycyclic hydrocarbon carcinogenesis and toxicity. Fed. Proc. 31, 1298 (1972)
Guirgis, H. R., Lynch, H. T., Mate, T., Harris, R. E., Wells, I., Caha, L., Anderson, J., Maloney, K., Rankin, L.: Aryl hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls. Oncology 33, 105 (1976)
Hart, P., Farell, G. C., Cooksley, W. G. E., Powell, L. W.: Enhanced drug metabolism in cigarette smokers. Br. Med. J. 2, 147 (1976)
Huffmann, D. H., Shoeman, D. W., Azarnoff, D. L.: Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxyantipyrine in the urine of man. Biochem. Pharmacol. 23, 197 (1974)
Inaba, T., Tang, B. K., Endrenyi, L., Kalow, W.: Amobarbital—a probe of hepatic drug oxidation in man. Clin. Pharmacol. Ther. 20, 439 (1976)
Kapitulnik, J., Poppers, P. J., Conney, A. H.: Comparative metabolism of benzo[a]pyrene and drugs in human liver. Clin. Pharmacol. Ther. 21, 166 (1977)
Kato, R., Takanaka, A., Oshima, T.: Drug metabolism in tumor bearing rats. II. In vivo metabolism and effects of drugs in tumor-bearing rats. Jpn. J. Pharmacol. 18, 245 (1968 a)
Kato, R., Takanaka, A., Takahashi, A., Onada, K.: Drug metabolism in tumor-bearing rats. I. Activities of NADPH-linked electron transport and drug metabolizing enzyme systems in liver microsomes of tumor-bearing rats. Jpn. J. Pharmacol. 18, 224 (1968 b)
Kellermann, G., Luyten-Kellermann, M., Shaw, C. R.: Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet. 25, 327 (1973 a)
Kellermann, G., Shaw, C. R., Luyten-Kellermann, M.: Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 289, 934 (1973 b)
Kellermann, G., Luyten-Kellermann, M., Horning, M. G., Stafford, M.: Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone. Drug Metab. Dispos. 3, 47 (1975)
Kellermann, G., Luyten-Kellermann, M., Horning, M. G., Stafford, M.: Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes. Clin. Pharmacol. Ther. 20, 72 (1976)
Kellermann, G., Luyten-Kellermann, M.: Phenobarbital induced drug metabolism in man. Toxicol. Appl. Pharmacol. 39, 97 (1977)
Kouri, R. E., Salerno, R. A., Whitmire, C. E.: Relationships between aryl hydrocarbon hydroxylase inducibility and sensitivity to chemically induced subcutaneous sarcomas in various strains of mice. J. Natl. Cancer Inst. 50, 363 (1973)
Kuntzman, R., Mark, L. C., Brand, L., Jacobson, M., Levin, W., Conney, A. H.: Metabolism of drugs and carcinogens by human liver enzymes. J. Pharmacol. Exp. Ther. 152, 151 (1966)
Lake, R. S., Pezutti, M. R., Kropko, M. L., Freeman, A. E., Igel, H. J.: Measurement of benzo[a]-pyrene metabolism in human monocytes. Cancer Res. 37, 2530 (1977)
Levin, W., Conney, A. H., Alvares, A. P., Merkatz, I., Kappas, A.: Induction of benzo[a]pyrene hydroxylase in human skin. Science 176, 419 (1972)
Nebert, D. W., Winker, J., Gelboin, H. V.: Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. Cancer Res. 29, 1763 (1969)
Paigen, B., Gurtoo, H. L., Minowada, J., Houten, L., Vincent, R., Paigen, B., Bejba, N., Ward, E., Hayner, N. T.: Questionable relation of aryl hydrocarbon hydroxylase to lung-cancer risk. N. Engl. J. Med. 297, 346 (1977)
Rosso, R., Danelli, M., Franchi, G., Garratini, S.: Impairment of drug metabolism in tumorbearing animals. Eur. J. Cancer 7, 565 (1971)
Silverberg, E.: Cancer Statistics, 1977. CA 27, 26 (1977)
Tokuhata, G. K., Lillienfeld, A. M.: Familial aggregation of lung cancer in humans. J. Natl. Cancer Inst. 30, 289 (1963)
Trell, E., Korsgaard, R., Hood, B.: Aryl hydrocarbon hydroxylase inducibility and laryngeal carcinomas. Lancet 1976 II, 140
Vesell, E., Page, J.: Genetic control of drug levels in man: Antipyrine. Science 161, 72 (1968)
Vesell, E. S., Passananti, G. T., Glenwright, P. A., Dvorchik, B. H.: Studies on the disposition of antipyrine, aminopyrine and phenacetin using plasma, saliva, and urine. Clin. Pharmacol. Ther. 18, 259 (1975)
Vestal, R. E., Norris, A. H., Tobin, J. D., Cohen, B. H., Shock, N. W., Andres, R.: Antipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking. Clin. Pharmacol. Ther. 18, 425 (1975)
Wattenberg, L. W.: Chemoprophylaxis of carcinogenesis: A review. Cancer Res. 26, 1520 (1966)
Welch, R. M., Harrison, Y. E., Conney, A. H., Poppers, P. J., Finster, M.: Cigarette smoking: Stimulatory effect on metabolism of 3,4-benzo[a]pyrene by enzymes in human placenta. Science 160, 541 (1968)
Whitlock, J. P., Cooper, H. L., Gelboin, H. V.: Aryl hydrocarbon (benzopyrene) hydroxylase is stimulated in human lymphocytes by mitogens and benz[o]anthracene. Science 177, 618 (1972)
Wilson, J.: Hepatic drug metabolism in rats bearing a mammotropic tumor. Pharmacologist 9, 202 (1967)
Yang, S. K., McCourt, D. W., Roller, P. P.: Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol-epoxide r-7,l-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo-[ajpyrene through a single enantiomer of r-7,5-8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. USA 73, 2594 (1976)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kellermann, G., ten-Kellermann, M.L., Jett, J.R., Moses, H.L., Fontana, R.S. (1978). Aryl Hydrocarbon Hydroxylase in Man and Lung Cancer. In: Vogel, F., Buselmaier, W., Reichert, W., Kellermann, G., Berg, P. (eds) Human Genetic Variation in Response to Medical and Environmental Agents: Pharmacogenetics and Ecogenetics. Human Genetics, Supplement, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67179-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-67179-1_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-09175-2
Online ISBN: 978-3-642-67179-1
eBook Packages: Springer Book Archive